Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2)

International Immunology

Volumn 21, Issue 6, 2009, Pages 621-632

  Boehme, Stefen A ^a   Franz Bacon, Karin ^a   Chen, Edward P ^a   Ly, Tai Wei ^a   Kawakami, Yuko ^b   Bacon, Kevin B ^a  

^a Actimis Pharmaceuticals Inc   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Allergy; Chemotaxis; Inflammation; Prostaglandin D2

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN D2; CALCIUM ION; CD23 ANTIGEN; CD30 ANTIGEN; CHEMOATTRACTANT RECEPTOR HOMOLOGOUS MOLECULE EXPRESSED ON TH CLASS 2 CELL; EOTAXIN; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 6; L SELECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PERTUSSIS TOXIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; RANTES; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL MIGRATION; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH2 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD30; BONE MARROW; CALCIUM; CELL MOVEMENT; CELLS, CULTURED; HYPERSENSITIVITY, DELAYED; L-SELECTIN; MAST CELLS; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROSTAGLANDIN D2; RECEPTORS, IGE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

EID: 66249145022     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp031     Document Type: Article

References (43)

1. Wedemeyer, J., Tsai, M. and Galli, S. J. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12:624.
2. Gurish, M. F. and Boyce, J. A. 2006. Mast cells: Ontogeny, homing, and recruitment of a unique innate effector cell. J. Allergy Clin. Immunol. 117:1285.
3. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4:787.
4. Kirshenbaum, A. S., Goff, J. P., Semere, T., Foster, B., Scott, L. M. and Metcalfe, D. D. 2007. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 6:313.
5. Nakano, T., Sonoda, T., Hayashi, C. et al. 1985. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162:1025.
6. Kitamura, Y., Go, S. and Hatanaka, K. 1978. Decrease of mast cells in W/ Wv mice and their increase by bone marrow transplantation. Blood 52:447.
7. Reynolds, D. S., Stevens, R. L., Lane, W. S., Carr, M. H., Austen, K. F. and Serafin, W. E. 1990. Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases. Proc. Natl Acad. Sci. USA 87:3230.
8. Miller, H. R. and Pemberton, A. D. 2002. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105:375.
9. Boyce, J. A. 2007. Mast cells and eicosanoid mediators: A system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 217:168.
10. Kim, N. and Luster, A. D. 2007. Regulation of immune cells by eicosanoid receptors. Scientific World Journal 7:1307.
11. Urade, Y., Ujihara, M., Horiguchi, Y. et al. 1990. Mast cells contain spleen-type prostaglandin D synthetase. J. Biol. Chem. 265:371.
12. Lu, R., Kanai, N., Bao, Y. and Schuster, V. L. 1996. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J. Clin. Invest. 98:1142.
13. Pettipher, R., Hansel, T. T. and Armer, R. 2007. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat. Rev. Drug Discov. 6:313.
14. Boie, Y., Sawyer, N., Slipetz, D. M., Metters, K. M. and Abramovitz, M. 1995. Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 270:18910.
15. Nagata, K., Tanaka, K., Ogawa, K. et al. 1999. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162:1278.
16. Yoshimura-Uchiyama, C., Iikura, M., Yamaguchi, M. et al. 2004. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin. Exp. Allergy 34:1283.
17. Gervais, F. G., Cruz, R. P., Chateauneuf, A. et al. 2001. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108:982.
18. Nishimoto, H., Lee, S. W., Hong, H. et al. 2005. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106:4241.
19. Boehme, S. A. and Lenardo, M. J. 1996. TCR-mediated death of mature T lymphocytes occurs in the absence of p53. J. Immunol. 156:4075.
20. Sugimoto, H., Shichijo, M., Iino, T. et al. 2003. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J. Pharmacol. Exp. Ther. 305:347.
21. Boehme, S. A., Sullivan, S. K., Crowe, P. D. et al. 1999. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J. Immunol. 163:1611.
22. Franz-Bacon, K., Dairaghi, D. J., Boehme, S. A. et al. 1999. Human thymocytes express CCR-3 and are activated by eotaxin. Blood 93:3233.
23. Weller, C. L., Collington, S. J., Brown, J. K. et al. 2005. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J. Exp. Med. 201:1961.
24. Hata, A. N., Zent, R., Breyer, M. D. and Breyer, R. M. 2003. Expression and molecular pharmacology of the mouse CRTH2 receptor. J. Pharmacol. Exp. Ther. 306:463.
25. Kuehn, H. S., Beaven, M. A., Ma, H. T., Kim, M. S., Metcalfe, D. D. and Gilfillan, A. M. 2008. Synergistic activation of phospholipases Cγ and Cβ: A novel mechanism for PI3K-independent enhancement of FceRI-induced mast cell mediator release. Cell. Signal. 20:625.
26. Gomi, K., Zhu, F. G. and Marshall, J. S. 2000. Prostaglandin E2 selectively enhances IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism. J. Immunol. 165:6545.
27. Nguyen, M. T., Solle, M., Audoly, L. P. et al. 2002. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J. Immunol. 169:4586.
28. Turner, H. and Kinet, J. P. 1999. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 402:B24.
29. Hirasawa, N., Scharenberg, A., Yamamura, H., Beaven, M. A. and Kinet, J. P. 1995. A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor. J. Biol. Chem. 270:10960.
30. 2 on helper T cell functions. Biochem. Biophys. Res. Commun. 316:1009.
31. Hammad, H., de Heer, H. J., Soullie, T., Hoogsteden, H. C., Trottein, F. and Lambrecht, B. N. 2003. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J. Immunol. 171:3936.
32. Okayama, Y., Ra, C. and Saito, H. 2007. Role of mast cells in airway remodeling. Curr. Opin. Immunol. 19:687.
33. Leung, D. Y. 1999. Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 104:S99.
34. Juliusson, S., Pipkorn, U., Karlsson, G. and Enerbäck, L. 1992. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: Changes in distribution and signs of activation in relation to symptoms. J. Allergy Clin. Immunol. 90:898.
35. Jiang, W. Y., Chattedee, A. D., Raychaudhuri, S. P., Raychaudhuri, S. K. and Farber, E. M. 2001. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int. J. Dermatol. 40:699.
36. Nigrovic, P. A. and Lee, D. M. 2005. Mast cells in inflammatory arthritis. Arthritis Res. Ther. 7:1.
37. Meininger, C. J., Yano, H., Rottapel, R., Bernstein, A., Zsebo, K. M. and Zetter, B. R. 1992. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79:958.
38. Matsuura, N. and Zetter, B. R. 1989. Stimulation of mast cell chemotaxis by interleukin 3. J. Exp. Med. 170:1421.
39. Lundeen, K. A., Sun, B., Karlsson, L. and Fourie, A. M. 2006. Leukotriene B4 receptors BLT1 and BLT2: Expression and function in human and murine mast cells. J. Immunol. 177:3439.
40. Fischer, M., Harvima, I. T., Carvalho, R. F. et al. 2006. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J. Clin. Invest. 116:2748.
41. Taub, D., Dastych, J., Inamura, N. et al. 1995. Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J. Immunol. 154:2393.
42. Papadopoulos, E. J., Fitzhugh, D. J., Tkaczyk, C. et al. 2000. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur. J. Immunol. 30:2355.
43. Kuehn, H. S. and Gilfillan, A. M. 2007. G protein coupled receptors and the modification of FcεRI-mediated mast cell activation. Immunol. Lett. 113:59.